24 May 2022
Monkeypox is a disease of global public health importance as it not only affects countries in West and Central Africa, but the rest of the world.
In May 2022, multiple cases of monkeypox were identified in several non-endemic countries. Professor Helen Rees has been a member of the World Health Organization’s (WHO) Strategic and Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH) since 2019. The Advisory Group had a meeting on Friday, 20 May 2022 to discuss the recent cases of monkeypox. STAG-IH will provide independent advice and analysis to WHO on the infectious hazards that may pose a potential threat to global health security. It has an umbrella function as the overarching group advising WHO on relevant infectious hazards. Rees is a member of the Scientific Advisory Board at NICD, and she is also a member of the South African National Advisory Group on Immunisation (NAGI). In her regional role as Chair of the AFRO Regional Immunisation Technical Advisory Group, Rees together with her colleagues are keeping a very close eye on the data with studies currently underway to further understand the epidemiology, sources of infection, and transmission patterns.Source: https://www.wits.ac.za/news/
100% increase in human rabies cases compared to 2020
The last few months have seen an increase in the number of human rabies cases.1,2 This is particularly worrying as with a 99.9% fatality rate, rabies is the deadliest disease on earth.3
Ascendis Health’s hastily reconvened annual general meeting (AGM) on Monday may have been a costly mistake for the wellness company, after it effectively triggered the cancellation of an agreement it had made with its lenders.
This Healthy Lifestyle Awareness Month, learn how genetic testing can help you determine which diet, lifestyle, and medication are best for your long-term health
We are at a pivotal moment in healthcare. Advances in both the understanding and accessibility of genetic testing are giving healthcare professionals and their patients a unique understanding of human biology with new ways to analyse health data.
SA pharmaceutical manufacturer Adcock Ingram has credited improved manufacturing output as well as sales and marketing strategies with driving strong interim results for the six months to 31 December 2021.
We provide end-to-end distribution for large clients from provincial departments and Large hospital networks to small retail pharmacies and medical product retailers.